The G-Rex Grant Program is HERE!!
The G-Rex® Grant Program is a $20 million initiative by ScaleReady, Wilson Wolf Manufacturing, Bio-Techne, and CellReady, that is designed to propel the advancement of cell and gene therapies (CGT).
Maintain high cell quality from research bench to clinical bedside.
Cell phenotype drift during scale-up is avoidable. G-Rex bioreactors, combined with high-quality reagents, maintain cell phenotype profiles across small and large scale expansion.
GMP raw materials for any process at any scale.
Raw material quality, supply, and process fit won’t be an issue. ScaleReady’s adaptable workflow, flexible filling, and supply agreements for GMP reagents ensure process customization and supply security as you scale.
The ScaleReady partners united to transform cell and gene therapy manufacturing with thoughtful leadership and design.
Latest ScaleReady news and events.
14 May 2025
ScaleReady awards multiple G-Rex® Grants to leading investigators at USC and CHLA
6 May 2025
ScaleReady awards a G-Rex® Grant to A2 Biotherapeutics, Inc.
29 April 2025
ScaleReady Announces March Biosciences as Recipient of G-Rex® Grant to Advance Manufacturing of Novel CAR-T Cell Therapy
Get in touch to begin scaling up and scaling out.
Let’s talk more about how ScaleReady can advance your cell and gene therapy research and manufacturing with ingenious efficiency.